Pacific Biosciences of California (PACB)
Healthcare
Medical Devices
1.40 $
+1.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Pacific Biosciences of California (PACB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -45 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -49 | -65 | -58 | -76 | -54 | -45 | -31 | -44 | -29 | -19 | -19 | -45 | -112 | |
| 4.9 | 5.5 | 12 | 12 | 14 | 16 | 11 | 373 | 4.6 | 4.4 | 4.6 | 4.1 | 18 | |
| 18 | 20 | 17 | 20 | 17 | 18 | 16 | 9.2 | 12 | 11 | 9.6 | 4.5 | 37 | |
| 23 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.5 | -13 | -7.7 | -25 | -6.3 | -17 | 8.4 | -2.4 | -3.9 | 3.2 | 7.5 | 3.2 | 10 | |
| 2.3 | 0.8 | 2.0 | 3.9 | 1.5 | 0.8 | 1.6 | 6.4 | 0.6 | 0.1 | 0.9 | 3.0 | 4.5 | |
| -99 | 242 | -67 | -34 | 77 | 23 | 58 | 45 | 25 | 19 | 26 | 36 | 106 | |
| 2.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -7.3 | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| 2.1 | -0.8 | -82 | 6.6 | -0.2 | 0.8 | -50 | 2.0 | 0.0 | 1.5 | -3.4 | 1.4 | -0.5 | |
| -145 | 176 | -206 | -103 | 23 | -21 | -23 | 3.1 | -4.1 | 1.7 | 7.0 | -7.4 | -2.9 | |
| -51 | -66 | -60 | -80 | -56 | -45 | -32 | -50 | -30 | -19 | -20 | -48 | -116 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.